Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03618199
Other study ID # Olith10101
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2018
Est. completion date September 30, 2023

Study information

Verified date May 2023
Source Otolith Labs
Contact Toni White
Phone 410.328.2473
Email toni.white@som.umaryland.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Testing for vestibular dysfunction often induces dizziness and nausea, to the point that testing cannot be completed. The investigators will use a "transcranial vibration system" that has shown promise in improving comfort during testing for vestibular disorders. The investigators hypothesize that with this "transcranial vibration system", the dizziness and nausea associated with caloric testing will be significantly reduced, while the clinical measures derived from the test will not be statistically significantly altered.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date September 30, 2023
Est. primary completion date July 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. Subject can speak and comprehend English. 2. Subject can stand a strap placed on their head for an hour. Exclusion Criteria: 1. History of head injury within the last six months 2. Presence of severe aphasia 3. History of diagnosed neuropsychiatric disorders 4. Documented neurodegenerative disorders 5. Pregnancy [Female candidates will be asked if they are pregnant] 6. History of Cerebrovascular disorders 7. History of ear operation other than myringotomy and tube placement in the past

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Efficacy of transcranial vibrating system on mitigating dizziness and nausea during caloric testing
Transcranial vibrating system will be on then off (or off then on in a random order) during a repeated application of the "calorics testing"stimulus, i.e. warm or cold water irrigated in the left (then right) ear canal. The effect of the vibrating system on 1) resulting dizziness and nausea often experienced by patients and 2) clinical parameters measured by caloric testing will be quantified.

Locations

Country Name City State
United States University of Maryland Baltimore Maryland

Sponsors (2)

Lead Sponsor Collaborator
Otolith Labs University of Maryland, Baltimore

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Nausea and dizziness Visual Analog Scales (VAS, adapted from "Visual Vertigo Analogue Scale" for dizziness and "Baxter Retching Faces (BARF)" for nausea) will be filled out by the subject ten minutes after each phase of the caloric testing, i.e. "with" and "without" the transcranial vibration system.Each phase of the caloric testing itself takes approximately 30 minutes.
These Visual Analog Scales range from 0 to 10 (None to Agonizing). They will provide independent measures of the effectiveness of the transcranial vibration system.
VAS administered ten minutes post-caloric testing; data will be analyzed upon study completion, estimated to last 6 weeks
Primary Vestibular testing outcomes Nystagmus associated with caloric testing (the primary clinical measure derived from caloric testing) will be compared, in the "with device" and "without device" conditions. Vestibular clinical measures will be analyzed by a clinician upon study completion, estimated to last 6 weeks.
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04196933 - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma N/A
Completed NCT05427097 - Thermal Energy in the Treatment of Cervicogenic Dizziness N/A
Completed NCT02299128 - Effectiveness of Early Physical Therapy Intervention for Patients With Dizziness After a Sports-Related Concussion N/A
Completed NCT02733549 - Is The Sudden Onset of Dizziness A Symptom of Acute Liver Dysfunction? N/A
Completed NCT05812209 - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Not yet recruiting NCT03973658 - Dizziness Among First Time Users of Hearing Aids
Completed NCT03182868 - Vestibular Testing: Consistency and Effects Over Time N/A
Completed NCT02938221 - Telemedical Examination of a Three-Component Oculomotor Testing Battery N/A
Active, not recruiting NCT02655575 - Assessment and Treatment of Patients With Long-term Dizziness in Primary Care N/A
Completed NCT02772042 - Traction Manipulation of Upper Cervical Spine on Cervicogenic Dizziness N/A
Completed NCT00732797 - A Trial of Booklet Based Self Management of Dizziness N/A
Not yet recruiting NCT06010550 - Validating a Clinical Decision Support Tool for Stratifying Stroke Risk for Dizziness/Vertigo
Completed NCT03330262 - Head-Mounted Vibrotactile Prosthesis for Patients With Chronic Postural Instability N/A
Completed NCT05157399 - Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness N/A
Completed NCT02344446 - Physical Therapy Intervention for Extended Physical Symptoms After a Sports-related Concussion N/A
Withdrawn NCT00732108 - Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated Dizziness N/A
Active, not recruiting NCT05122663 - Emergency Department Vestibular Rehabilitation Therapy for Dizziness and Vertigo
Recruiting NCT05634902 - Implementation of Evidence-Based Practice for Dizziness N/A
Completed NCT02640599 - Stationary Bike Study N/A
Enrolling by invitation NCT05990023 - The Effect of Computerized Vestibular Function Assessment and Training System Combined With Cognitive/Motor Dual-task N/A